Quiz for Clinicians
Reviewed by: HU Medical Review Board | Last reviewed: June 2026 | Last updated: July 2026
Psoriatic arthritis (PsA) sits at the intersection of rheumatology, dermatology, and cardiometabolic medicine, and the field is moving quickly. This 5-question quiz is designed for clinicians who manage PsA. It spans diagnosis and classification, cardiovascular risk, the expanding treatment landscape, and findings from recent trials. Continue reading to test your knowledge!
Clinical Challenge
Within the CASPAR criteria, which single feature is weighted at 2 points rather than 1?
Clinical Challenge
Which statement best reflects current understanding of cardiovascular risk in PsA?
Clinical Challenge
Per the 2023 EULAR pharmacological recommendations, where do JAK inhibitors sit for a 67-year-old PsA patient with peripheral arthritis, a smoking history, and prior atherosclerotic disease who has failed a TNF inhibitor?
Clinical Challenge
Per the GRAPPA 2021 recommendations, which 2 drug classes are recommended as first-line options for moderate-to-severe disease across all 6 PsA domains?
Clinical Challenge
In the SEAM-PsA randomized trial comparing methotrexate monotherapy, etanercept monotherapy, and their combination in PsA, the key finding was: